BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10439523)

  • 21. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
    Seminario-Vidal L; Sami N; Miller J; Theos A
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of relapsing polychondritis with mycophenolate mofetil.
    Goldenberg G; Sangueza OP; Jorizzo JL
    J Dermatolog Treat; 2006; 17(3):158-9. PubMed ID: 16854756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids.
    Grotz W; von Zedtwitz I; Andre M; Schollmeyer P
    Lancet; 1998 Oct; 352(9135):1195. PubMed ID: 9777843
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil.
    Goyal S; Nousari HC
    J Am Acad Dermatol; 2001 Jul; 45(1):142-4. PubMed ID: 11423853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil: new applications for this immunosuppressant.
    Moder KG
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy.
    Polenakovic M; Grcevska L; Dzikova S
    Nephrol Dial Transplant; 2003 Jun; 18(6):1233-4. PubMed ID: 12748370
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycophenolate mofetil.
    Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
    Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of lichen planopilaris with mycophenolate mofetil.
    Tursen U; Api H; Kaya T; Ikizoglu G
    Dermatol Online J; 2004 Jul; 10(1):24. PubMed ID: 15347506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A.
    Eisert S; Mosler K; Laws HJ; Göbel U
    Thromb Haemost; 2005 Apr; 93(4):792-3. PubMed ID: 15841330
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycophenolate mofetil.
    Zwerner J; Fiorentino D
    Dermatol Ther; 2007; 20(4):229-38. PubMed ID: 17970888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of mycophenolate mofetil therapy on the phenotypic profile of peripheral blood leukocyte populations in psoriatic patients.
    Daudén E; Pedraz J; Pérez-Gala S; Muñoz C; Vitón M; Onate MJ; García-Díez A
    Eur J Dermatol; 2010; 20(2):233-4. PubMed ID: 20007061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.